Lisa U. Teufel
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Interleukin-38 is a negative regulator of trained immunity-A retrospective multi-omics study.
Journal: iScience
Published: April 03, 2025
Insights into the multifaceted role of interleukin-37 on human immune cell regulation.
Journal: Clinical immunology (Orlando, Fla.)
Published: June 29, 2024
Interleukin 38 reduces antigen-presentation capacity and antibody production after vaccination.
Journal: Vaccine
Published: June 10, 2024
Protocol to culture Leishmania protozoans for lipophosphoglycan extraction and purification.
Journal: STAR protocols
Published: May 31, 2024
Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania spp.
Journal: Immunology letters
Published: April 29, 2024
Leishmania braziliensis enhances monocyte responses to promote anti-tumor activity.
Journal: Cell reports
Published: April 16, 2023
Opposing Effects of Interleukin-36γ and Interleukin-38 on Trained Immunity.
Journal: International journal of molecular sciences
Published: December 28, 2022
Exploratory analysis of interleukin-38 in hospitalized COVID-19 patients.
Journal: Immunity, inflammation and disease
Published: July 29, 2022
Circulating interleukin-38 concentrations in healthy adults.
Journal: Frontiers in immunology
Published: June 08, 2022
Bimodal Targeting of Human Leukocytes by Fc- and CpG-Decorated Polymersomes to Tune Immune Induction.
Journal: Biomacromolecules
Published: September 23, 2021
Last Updated: 09/26/2026